Skip to main content Accessibility help
×
Home
Hostname: page-component-55597f9d44-mzfmx Total loading time: 1.611 Render date: 2022-08-18T05:59:48.853Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true } hasContentIssue true

56 - Western Pacific ALS/parkinsonism–dementia complex

from Part IX - Motor neuron diseases

Published online by Cambridge University Press:  04 August 2010

M. Flint Beal
Affiliation:
Cornell University, New York
Anthony E. Lang
Affiliation:
University of Toronto
Albert C. Ludolph
Affiliation:
Universität Ulm, Germany
Daniel P. Perl
Affiliation:
Department of Pathology, Neuropathology Division, Fishberg Research Center for Neurobiology
Patrick R. Hof
Affiliation:
Fishberg Research Center for Neurobiology, Kastor Neurobiology of Aging Laboratories, Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029
Get access

Summary

Introduction

Guam, the southernmost of the Marianas, an archipelago consisting of a chain of 15 islands, is the largest island in the western Pacific. The Marianas are part of Micronesia, a group of Pacific islands that, in addition to the Marianas, consists of the Carolines, the Marshalls, and the Gilberts. Guam is a relatively small island measuring approximately 20 miles long and from 4 to 9 miles wide (total area, 212 square miles). Located at 13 degrees north of the equator, Guam is approximately 3500 miles west of Hawaii, 1500 miles south of Tokyo and 1500 east of Manila. Guam was obtained by the United States as a territorial possession in 1898, as part of the settlement of the Spanish–American War. In the early portion of the twentieth century, Guam served as valuable stopping off place for coal-burning steamships needing to take on fresh water and other vital supplies during their long ocean-going voyages. From a military perspective, Guam's strategic central location in the western Pacific was also important and the United States Navy administered the island from 1898 until 1950 (with the exception of the Japanese occupation during World War II). In 1950, the Organic Act of Guam was passed by the US Congress and gave the inhabitants of Guam United States citizenship. This law also gave the inhabitants of Guam the right to elect a local governor and island legislature, and to send a non-voting representative to the US Congress.

Type
Chapter
Information
Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 827 - 844
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, F. H., Richardson, E. P., Okazaki, H. & Brody, J. A. (1979). Neurofibrillary degeneration on Guam. Frequency in Chamorros and non-Chamorros with no known neurological disease. Brain, 102, 65–77CrossRefGoogle ScholarPubMed
Arnold, A., Edgren, D. C. & Palladino, V. S. (1953). Amyotrophic lateral sclerosis. Fifty cases observed on Guam. J. Nerv. Ment. Dis., 117, 135–9CrossRefGoogle ScholarPubMed
Ashkog, J. E., Waring, S. C., Petersen, R. C.et al. (1994). Guamanian neurodegenerative disease: failure to find abnormal calcium metabolism. Neurology, 44, S2, 193–9Google Scholar
Ball, M. J. & Lo, L. (1977). Granulovacuolar degeneration in the ageing brain and in dementia. J. Neuropathol. Exp. Neurol., 36, 474–87CrossRefGoogle ScholarPubMed
Banack, S. A. & Cox, P. A. (2003). Biomagnification of cycad neurotoxins in flying foxes: implications for ALS–PDC in Guam. Neurology, 61, 387–9CrossRefGoogle ScholarPubMed
Buée, L., Hof, P. R., Bouras, C.et al. (1994). Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathologica, Berlin, 87, 469–80CrossRefGoogle ScholarPubMed
Buée, L., Perez-Tur, J., Leveugle, B.et al. (1996). Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathologic changes. Acta Neuropathol.(Berl.), 91, 247–53Google Scholar
Buée-Scherrer, V., Buée, L., Hof, P. R.et al. (1995a). Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: immunochemical characterization of tau proteins. Am. J. Pathol., 68, 924–32Google Scholar
Buée-Scherrer, V., Buée, L., Hof, P. R. et al. (1995b). Tau variants in aging and neurodegenerative disease. Alzheimer's Disease: Lessons from Cell Biology, ed. K. S. Kosik, pp. 132–49. Berlin, Springer-Verlag
Bunina, T. L. (1962). On intracellular inclusions in familial amyotrophic lateral sclerosis. Korsakov J. Neuropathol. Psychiatry, 62, 1293–9Google ScholarPubMed
Chen, K. M., Makifuchi, T., Garruto, R. M. & Gajdusek, D. C. (1982). Parkinsonism-dementia in a Filipino migrant: a clinicopathologic case report. Neurology, 32, 1221–6CrossRefGoogle Scholar
Cox, P. A., Banack, S. A. & Murch, S. J. (2003). Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc. Natl Acad. Sci., USA, 100, 13380–3CrossRefGoogle ScholarPubMed
Cox, P. A. & Sacks, O. W. (2002). Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology, 58, 956–9CrossRefGoogle ScholarPubMed
Duncan, M. W. (1991). Role of the cycad neurotoxin BMAA in the amyotrophic lateral sclerosis–parkinsonism dementia complex of the western Pacific. Adv. Neurol., 56, 301–10Google ScholarPubMed
Duncan, M. W., Steele, J. C., Kopin, I. J. & Markey, S. P. (1990). 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism–dementia of Guam. Neurology, 40, 767–72CrossRefGoogle ScholarPubMed
Duncan, M. W., Villacreses, N. E., Pearson, P. G.et al. (1991). 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood–brain-barrier permeability in the rat. J. Pharmacol. Exp. Ther., 258, 27–35Google ScholarPubMed
Duncan, M. W., Marini, A. M., Watters, R., Kopin, I. J. & Markey, S. P. (1992). Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional guamanian methods. J. Neurosci., 12, 1523–37CrossRefGoogle ScholarPubMed
Eldridge, R., Ryan, E., Rosario, J. & Brody, J. A. (1969). Amyotrophic lateral sclerosis and parkinsonism–dementia in a migrant population from Guam. Neurology, 19, 1029–37CrossRefGoogle Scholar
Elizan, T. S., Hirano, A., Abrams, B. M., Need, R. L., Nuis, C. & Kurland, L. T. (1966). Amyotrophic lateral sclerosis and parkinsonism–dementia complex of Guam. Neurological reevaluation. Arch. Neurol., 14, 356–68CrossRefGoogle ScholarPubMed
Forman, M. S., Schmidt, M. L., Kasturi, S., Perl, D. P., Lee, V. M. & Trojanowski, J. Q. (2002). Tau and alpha-synuclein pathology in amygdala of Parkinsonism–dementia complex patients of Guam. Am. J. Pathol., 160, 1725–31CrossRefGoogle ScholarPubMed
Gajdusek, D. C. (1963). Motor neuron disease in natives of New Guinea. N. Engl. J. Med., 268, 474–6CrossRefGoogle ScholarPubMed
Gajdusek, D. C. (1977). Unconventional viruses and the origin and disappearance of kuru. Science, 197, 943–60CrossRefGoogle ScholarPubMed
Gajdusek, D. C. & Salazar, A. M. (1980). Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people in West New Guinea. Neurology, 32, 107–26CrossRefGoogle Scholar
Galasko, D., Salmon, D., Craig, U. K. & Wiederholt, W. (2000). The clinical spectrum of Guam ALS and Parkinson–dementia complex: 1997–1999. Ann. NY Acad. Sci., 920, 120–5CrossRefGoogle ScholarPubMed
Galasko, D., Salmon, D. P., Craig, U. K., Thal, L. J., Schellenberg, G. & Wiederholt, W. (2002). Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997–2000. Neurology, 58, 90–7CrossRefGoogle ScholarPubMed
Galloway, P. G., Perry, G. & Gambetti, P. (1987a). Hirano bodies contain actin and actin-associated proteins. J. Neuropath. Exp. Neurol., 46, 185–99CrossRefGoogle Scholar
Galloway, P. G., Perry, G., Kosik, K. & Gambetti, P. (1987b). Hirano bodies contain tau protein. Brain Res., 403, 337–40CrossRefGoogle Scholar
Garruto, R. M., Fukatsu, R., Yanagihara, R., Gajdusek, D. C., Hook, G. & Fiori, C. (1984). Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism–dementia of Guam. Proc. Natl Acad. Sci., USA, 81, 1875–9CrossRefGoogle ScholarPubMed
Garruto, R. M., Gajdusek, D. C. & Chen, K. M. (1980). Amyotrophic lateral sclerosis among Chamorro migrants from Guam. Neurology, 8, 612–19Google ScholarPubMed
Garruto, R. M., Gajdusek, D. C. & Chen, K. M. (1981). Amyotrophic lateral sclerosis and parkinsonism–dementia among Filipino migrants to Guam. Ann. Neurol., 10, 341–50CrossRefGoogle ScholarPubMed
Garruto, R. M. & Yanagihara, R. (1991). Amyotrophic lateral sclerosis in the Marianas Islands. Handbook of Clinical Neurology, Vol. 15 (59), Diseases of the Motor System, ed. J. M. B. V. de Jung, pp. 253–71. Amsterdam: Elsevier Scientific Publishers
Garruto, R. M., Yanagihara, R. & Gajdusek, D. C. (1985). Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism–dementia on Guam. Neurology, 35, 193–8CrossRefGoogle ScholarPubMed
Gentleman, S. M., Perl, D., Allsop, D., Clinton, J., Royston, M. C. & Roberts, G. W. (1991). Beta (A4)-amyloid protein and parkinsonian dementia complex of Guam. Lancet, 337, 55–6CrossRefGoogle ScholarPubMed
Gibbs, C. J. Jr. & Gajdusek, D. C. (1982). An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia and Parkinson's disease. Adv. Neurol., 36, 343–53Google ScholarPubMed
Gibson, P. H. & Tomlinson, B. E. (1977). Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease. J. Neurol. Sci., 33, 199–206CrossRefGoogle ScholarPubMed
Goldman, J. E. (1983). The association of actin with Hirano bodies. J. Neuropath. Exp. Neurol., 42, 146–52CrossRefGoogle ScholarPubMed
Good, P. F., Olanow, C. W. & Perl, D. P. (1992). Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res., 593, 343–6CrossRefGoogle ScholarPubMed
Good, P. F. & Perl, D. P. (1993). Aluminium in Alzheimer's? Nature, 362, 418CrossRefGoogle ScholarPubMed
Good, P. F. & Perl, D. P. (1994). A quantitative comparison of aluminum concentration in neurofibrillary tangles of Alzheimer's disease and parkinsonian dementia complex of Guam by laser microprobe mass analysis. Neurobiol. Agin., 15, S28–30Google Scholar
Gurney, M. E., Pu, H., Chiu, A. Y.et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772–5CrossRefGoogle ScholarPubMed
Gutteridge, J. M., Quinlan, G. J., Clark, I. & Halliwell, B. (1985). Aluminum salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochem. Biophys. Act., 835, 441–7CrossRefGoogle ScholarPubMed
Hirano, A. (1973). Progress in the pathology of motor neuron diseases. Prog. Neuropath., 2, 181–215Google Scholar
Hirano, A. (1994). Hirano bodies and related neuronal inclusions. Neuropath. Appl. Neurobiol., 20, 3–11CrossRefGoogle ScholarPubMed
Hirano, A., Arumugasamy, N. & Zimmerman, H. M. (1967a). Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. Arch. Neurol., 16, 357–63CrossRefGoogle Scholar
Hirano, A., Dembitzer, H. M., Kurland, L. T. & Zimmerman, H. M. (1968). The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and “rod-like” structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism–dementia complex. J. Neuropathol. Exp. Neurol., 27, 167–82CrossRefGoogle ScholarPubMed
Hirano, A., Kurland, L. T., Krooth, R. S. & Lessell, S. (1961a). Parkinsonism–dementia complex, an endemic disease on the island of Guam I. Clinical features. Brain, 84, 642–61CrossRefGoogle Scholar
Hirano, A., Kurland, L. T. & Sayre, G. P. (1967b). Familial amyotrophic lateral sclerosis: a subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horns. Arch. Neurol., 16, 232–43CrossRefGoogle Scholar
Hirano, A., Malamud, N. & Kurland, L. T. (1961b). Parkinsonism–dementia complex, an endemic disease on the island of Guam II. Pathological features. Brain, 84, 662–79CrossRefGoogle Scholar
Hirano, A. & Zimmerman, H. M. (1962). Alzheimer's neurofibrillary changes. A topographic study. Neurology, 7, 227–42Google ScholarPubMed
Hirsch, E. C., Brandel, J. P., Galle, P., Javoy-Agid, F. & Agid, Y. (1991). Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem., 56, 446–51CrossRefGoogle ScholarPubMed
Hof, P. R., Bouras, C., Buée, L., Delacourte, A., Perl, D. P. & Morrison, J. H. (1992a). Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol. Berl., 85, 23–30CrossRefGoogle Scholar
Hof, P. R., Charpiot, A., Delacourte, A. et al. (1992b). Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neurosci. Lett., 139, 10–14CrossRefGoogle Scholar
Hof, P. R., Delacourte, A. & Bouras, C. (1992c). Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol. Berl., 84, 45–51CrossRefGoogle Scholar
Hof, P. R. & Perl, D. P. (2002). Neurofibrillary tangles in the primary motor cortex in Guamanian amyotrophic lateral sclerosis/parkinsonism–dementia complex. Neurosci. Lett., 328, 294–8CrossRefGoogle ScholarPubMed
Hof, P. R., Perl, D. P., Loerzel, A. J. & Morrison, J. H. (1991). Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism–dementia cases from Guam: differences with Alzheimer's disease. Brain Res., 564, 306–13CrossRefGoogle ScholarPubMed
Hof, P. R., Perl, D. P., Loerzel, A. J., Steele, J. C. & Morrison, J. H. (1994). Amyotrophic lateral sclerosis and parkinsonism-dementia from Guam: differences in neurofibrillary tangle distribution and density in the hippocampal formation and neocortex. Brain Res., 650, 107–16CrossRefGoogle ScholarPubMed
Ito, H., Goto, S., Hirano, A. & Yen, S. H. (1991). Immunohistochemical study of the hippocampus in parkinsonism-dementia complex on Guam. J. Geriat. Psychiatry & Neurol., 4, 134–42Google ScholarPubMed
Itoh, N., Ishiguro, K., Arai, H.et al. (2003). Biochemical and ultrastructural study of neurofibrillary tangles in amyotrophic lateral sclerosis/parkinsonism–dementia complex in the Kii peninsula of Japan. J. Neuropathol. Exp. Neurol., 62, 791–8CrossRefGoogle Scholar
Khabazian, I., Bains, J. S., Williams, D. E.et al. (2002). Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J. Neurochem., 82, 516–28CrossRefGoogle ScholarPubMed
Klatzo, I., Wisniewski, H. & Streicher, E. (1965). Experimental production of neurofibrillary pathology: I. Light microscopic observations. J. Neuropathol. Exp. Neurol., 24, 187–99CrossRefGoogle ScholarPubMed
Koerner, D. R. (1952). Amyotrophic lateral sclerosis on Guam: a clinical study and review of the literature. Ann. Int. Med., 37, 1204–20Google Scholar
Kokubo, Y., Kuzuhara, S. & Narita, Y. (2000). Geographical distribution of amyotrophic lateral sclerosis with neurofibrillary tangles in the Kii Peninsula of Japan. J. Neurol., 247, 850–2CrossRefGoogle ScholarPubMed
Kurland, L. T. & Mulder, D. W. (1954). Epidemiologic investigations of amyotrophic lateral sclerosis. 1. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations. Neurology, 4, 355–78, 438–48CrossRefGoogle Scholar
Kurland, L. T., Mulder, D. W., Sayre, G. P.et al. (1956). Amyotrophic lateral sclerosis in the Marianas Islands. Arch. Neurol. Psychiatr., 75, 435–41CrossRefGoogle Scholar
Kuzuhara, S., Kokubo, Y., Sasaki, R.et al. (2001). Familial amyotrophic lateral sclerosis and parkinsonism–dementia complex of the Kii Peninsula of Japan: clinical and neuropathological study and tau analysis. Ann. Neurol., 49, 501–11CrossRefGoogle ScholarPubMed
Lepore, F. E., Steele, J. C., Cox, T. A.et al. (1988). Supranuclear disturbances of ocular motility in Lytico-Bodig. Neurology, 38, 1849–53CrossRefGoogle ScholarPubMed
Lessel, S., Hirano, A., Torres, J. & Kurland, L. T. (1962). Parkinsonism–dementia complex, epidemiologic considerations in the Chamorros of the Marianas islands, including clinical and pathologic observations. Arch. Neurolog., 7, 377–85CrossRefGoogle Scholar
Leveugle, B., Spik, G., Perl, D. P., Bouras, C., Fillit, H. M. & Hof, P. R. (1994). The iron-binding protein lactoferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res., 650, 20–31CrossRefGoogle Scholar
Linton, R. W., Bryan, S. R., Cox, X. B.et al. (1987). Digital imaging studies of aluminum and calcium in neurofibrillary tangle-bearing neurons using SIMS (secondary ion mass spectrometry). Trace Elements in Med., 4, 99–104Google Scholar
Malamud, N., Hirano, A. & Kurland, L. T. (1961). Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Neurology, 5, 401–14Google ScholarPubMed
Mawal-Dewan, M., Schmidt, L., Balin, B., Perl, D. P., Lee, V. M. Y. & Trojanowski, J. Q. (1996). Identification of phosphorylation sites in PHF-tau from patients with Guam amyotrophic lateral sclerosis/parkinsonism–dementia complex. J. Neuropathol. Exp. Neurol., 55, 1051–9CrossRefGoogle ScholarPubMed
McLachlan, D. R., McLachlan, C. D., Krishnan, B., Krishnan, S. S., Dalton, A. J. & Steele, J. C. (1989). Aluminum and calcium in soil and food from Guam, Palau and Jamaica: implications for amyotrophic lateral sclerosis and parkinsonism–dementia syndromes of Guam. Environm. Geochem. Hlth., 11, 45–53Google Scholar
Miller, W. R. & Sanzolone, R. F. (2003). Investigation of the possible connection of rock and soil geochemistry to the occurrence of high rates of neurodegenerative diseases on Guam and a hypothesis for the cause of the diseases. Denver, CO, US Department of the Interior, US Geological Survey: 1–44
Miura, K. (1902). Uber die amyotrophische lateralskerlose. Neurology Japonica 1, 1–15Google Scholar
Miura, K. (1911). Amyotrophische lateralsklerose unter dem blide von sog. bulbarparalyse. Neurology Japonica, 10, 366–369Google Scholar
Mirra, S. S., Heyman, A., McKeel, D.et al. (1991). The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41, 479–86CrossRefGoogle Scholar
Mourelatos, Z., Adler, H., Hirano, A., Donnenfeld, H., Gonatas, J. O. & Gonatas, N. K. (1990). Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis revealed by organelle-specific antibodies. Proc. Natl Acad. Sci., USA, 87, 4393–5CrossRefGoogle ScholarPubMed
Mourelatos, Z., Hirano, A., Rosenquist, A. & Gonatas, N. (1994). Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS). Clinical studies in ALS of Guam and experimental studies in deafferented neurons and in beta,beta-iminodipropionitrile axonopathy. Am. J. Pathol., 144, 1288–300Google ScholarPubMed
Olanow, C. W., Calne, D. B., Chu, N. S. & Perl, D. P. (1994). Manganese-induced neurotoxicity. Advances in Research on Neurodegeneration. Volume II. Etiopathogenesis, ed. Y. Mizuno, D. B. Calne & R. Horowski, pp. 53–62. Boston: BirkhauserCrossRef
Olanow, C. W. & Perl, D. P. (1994). Free radicals and neurodegeneration. Trends Neurosci., 17, 193–4Google Scholar
Perl, D. P. & Brody, A. R. (1980). Alzheimer's Disease: X-ray spectrographic evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science, 208, 297–9CrossRefGoogle Scholar
Perl, D. P., Gajdusek, D. C., Garruto, R. M., Yanagihara, R. T. & Gibbs, C. J. Jr. (1982). Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and parkinsonism–dementia of Guam. Science, 217, 1053–5CrossRefGoogle ScholarPubMed
Perl, D. P., Hof, P. R., Purohit, D. P., Loerzel, A. J. & Kakulas, B. A. (2003). Hippocampal and entorhinal cortex neurofibrillary tangle formation in Guamanian Chamorros free of overt neurologic dysfunction. J. Neuropathol. Exp. Neurol., 62, 381–8CrossRefGoogle ScholarPubMed
Perl, D. P., Hof, P. R., Steele, J. C.et al. (1994). Marianas dementia: a purely dementing form of ALS/parkinsonism–dementia complex of Guam. Soc. Neurosci. Abst., 20, 1649–50Google Scholar
Piccardo, P., Yanagihara, R., Garruto, R. M., Gibbs, C. J., Jr. & Gajdusek, D. C. (1988). Histochemical and X-ray microanalytical localization of aluminum in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Acta Neuropathol. Berl., 77, 1–4CrossRefGoogle ScholarPubMed
Purohit, D. P., Perl, D. P. & Steele, J. C. (1992). ALS/parkinsonism–dementia complex among Filipino migrants to Guam: report of two cases with parkinsonian features. J. Neuropathol. Exp. Neurol., 51, 323–30Google Scholar
Reed, D., Plato, C., Elizan, T. & Kurland, L. T. (1966). The amyotrophic lateral sclerosis/parkinsonism–dementia complex: a ten-year follow-up on Guam. Part I. Epidemiologic studies. Am. J. Epidemiol., 83, 54–73CrossRefGoogle Scholar
Reed, D. M. and Brody, J. A. (1975). Amyotrophic lateral sclerosis and parkinsonism–dementia of Guam, 1945–1972. I. Descriptive epidemiology. Am. J. Epidemiol., 101, 287–301CrossRefGoogle ScholarPubMed
Rogers-Johnson, P., Garruto, R. M., Yanagihara, R., Chen, K., Gajdusek, D. C. & Gibbs, C. J. Jr. (1986). Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathologic trends. Neurology, 36, 7–13CrossRefGoogle Scholar
Rosen, D. R., Siddique, T., Patterson, D.et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59–62CrossRefGoogle ScholarPubMed
Schmidt, M. L., Lee, V. M.-Y. & Trojanowski, J. Q. (1989). Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus. Laborat. Invest., 60, 513–22Google ScholarPubMed
Schnur, J. A., Chase, T. N. & Brody, J. A. (1971). Parkinsonism–dementia of Guam: treatment with L-dopa. Neurology, 21, 1236–42CrossRefGoogle ScholarPubMed
Shankar, S. K., Yanagihara, R., Garruto, R. M., Grundke-Iqbal, I., Kosik, K. S. & Gajdusek, D. C. (1989). Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism–dementia of Guam. Ann. Neurol., 25, 146–151CrossRefGoogle ScholarPubMed
Shaw, C. A. & Wilson, J. M. (2003). Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models. Neurosci. Biobehav. Rev., 27, 493–505CrossRefGoogle ScholarPubMed
Shiraki, H. & Yase, Y. (1975). Amyotrophic lateral sclerosis in Japan. Handbook of Clinical Neurology, Volume 22, ed. P. J. Vinken & G. W. Bruyn, pp. 353–419. New York, Elsevier
Shiraki, H. & Yase, Y. (1991). Amyotrophic lateral sclerosis and parkinsonism–dementia in the Kii Peninsula: comparison with the same disorders in Guam and with Alzheimer's disease. Handbook of Clinical Neurology, Vol. 15 (59), Diseases of the Motor System, ed. J. M. B. V. de Jung, pp. 273–300. Amsterdam: Elsevier Scientific Publishing
Spencer, P. S., Kisby, G. E., Ross, S. M.et al. (1993). Guam ALS–PDC: possible causes. Science, 262, 825–6CrossRefGoogle ScholarPubMed
Spencer, P. S., Nunn, P. B., Hugon, J.et al. (1987). Guam amyotrophic lateral sclerosis–parkinsonism–dementia linked to a plant excitant neurotoxin. Science, 237, 517–22CrossRefGoogle ScholarPubMed
Steele, J. C., Guzman, T. Q. & Driver, M. G. (1990). Nutritional factors in amyotrophic lateral sclerosis on Guam: observations from Umatac. Amyotrophic Lateral Sclerosis: Concepts in Pathogenesis and Etiology, ed. A. J. Hudson, pp. 193–223. Toronto: Univ. of Toronto Press
Stone, R. (1993). Guam: deadly disease dying out. Science, 261, 424–6CrossRefGoogle ScholarPubMed
Terry, R. D. & Pena, C. (1965). Experimental production of neurofibrillary pathology: electron microscopy, phosphate histochemistry and electron probe analysis. J. Neuropathol. Exp. Neurol., 24, 200–10CrossRefGoogle Scholar
Tomlinson, B. E. & Kitchener, D. (1972). Granulovacuolar degeneration of hippocampal pyramidal cells. J. Pathol., 106, 165–85CrossRefGoogle ScholarPubMed
Torres, J., Iriarte, L. L. & Kurland, L. T. (1957). Amyotrophic lateral sclerosis among Guamanians in California. California Med., 4, 385–8Google Scholar
Uebayashi, Y. (1984). Long survival cases of motor neuron disease in the Kii peninsula and Guam. Amyotrophic Lateral Sclerosis in Asia and Oceania, ed. K. M. Chen & Y. Yase, pp. 43–64. Taiwan: National Taiwan University
Umahara, T., Hirano, A., Kato, S., Shibata, N. & Yen, S. H. (1994). Demonstration of neurofibrillary tangles and neuropil thread-like structures in spinal cord white matter in parkinsonism–dementia complex on Guam and in Guamanian amyotrophic lateral sclerosis. Acta Neuropathol. Berl., 88, 180–4CrossRefGoogle ScholarPubMed
Wakayama, I., Kihira, T., Yoshida, S. & Garruto, R. M. (1993). Rare neuropil threads in amyotrophic lateral sclerosis and parkinsonism–dementia on Guam and in the Kii Peninsula of Japan. Dementia, 4, 75–80Google ScholarPubMed
Whiting, M. (1964). Toxicity of cycads. Econ. Botan., 17, 64–71Google Scholar
Whiting, M. (1988). Toxicity of Cycads: Implications for Neurodegenerative Diseases and Cancer. Transcripts of Four Cycad Conferences. New York: Third World Medical Research Foundation
Wiederholt, W. C. (1999). Neuroepidemiologic research initiative on Guam: past and present. Neuroepidemiology, 18, 279–91CrossRefGoogle Scholar
Wilson, J. M., Khabazian, I., Wong, M. C.et al. (2002). Behavioral and neurological correlates of ALS–parkinsonism dementia complex in adult mice fed washed cycad flour. Neuromolec. Med., 1, 207–21Google ScholarPubMed
Yahr, M. D. (1968). Encephalitis lethargica (Von Economo's disease, epidemic encephalitis). Handbook of Clinical Neurology, Volume 34. ed. P. J. Vinken & G. W. Bruyn. Amsterdam: Elsevier/North-Holland. pp. 451–7
Yamazaki, M., Arai, Y., Baba, M.et al. (2000). Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism–dementia complex of Guam. J. Neuropathol. Exp. Neurol., 59, 585–91CrossRefGoogle ScholarPubMed
Yase, Y. (1972). The pathogenesis of amyotrophic lateral sclerosis. Lancet, 2, 292–6CrossRefGoogle ScholarPubMed
Yase, Y., Chen, K. M., Brody, J. A. & Toyokura, Y. (1978). An historical note on the parkinsonism–dementia complex of Guam. Neurol. Med., 8, 583–9Google Scholar
Zimmerman, H. M. (1945). Monthly report to Medical Officer in Command. US Naval Medical Research Unit No.2

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Western Pacific ALS/parkinsonism–dementia complex
    • By Daniel P. Perl, Department of Pathology, Neuropathology Division, Fishberg Research Center for Neurobiology, Patrick R. Hof, Fishberg Research Center for Neurobiology, Kastor Neurobiology of Aging Laboratories, Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029
  • M. Flint Beal, Cornell University, New York, Anthony E. Lang, University of Toronto, Albert C. Ludolph, Universität Ulm, Germany
  • Book: Neurodegenerative Diseases
  • Online publication: 04 August 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544873.057
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Western Pacific ALS/parkinsonism–dementia complex
    • By Daniel P. Perl, Department of Pathology, Neuropathology Division, Fishberg Research Center for Neurobiology, Patrick R. Hof, Fishberg Research Center for Neurobiology, Kastor Neurobiology of Aging Laboratories, Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029
  • M. Flint Beal, Cornell University, New York, Anthony E. Lang, University of Toronto, Albert C. Ludolph, Universität Ulm, Germany
  • Book: Neurodegenerative Diseases
  • Online publication: 04 August 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544873.057
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Western Pacific ALS/parkinsonism–dementia complex
    • By Daniel P. Perl, Department of Pathology, Neuropathology Division, Fishberg Research Center for Neurobiology, Patrick R. Hof, Fishberg Research Center for Neurobiology, Kastor Neurobiology of Aging Laboratories, Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029
  • M. Flint Beal, Cornell University, New York, Anthony E. Lang, University of Toronto, Albert C. Ludolph, Universität Ulm, Germany
  • Book: Neurodegenerative Diseases
  • Online publication: 04 August 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544873.057
Available formats
×